Accelerating the development of new treatments for heart, lung, blood, and sleep disorders.
Official title: NHLBI CATALYZE PROGRAM - PRECLINICAL SERVICES COMPONENT - ADMINISTRATIVE SERVICES
Funded at Research Triangle Institute · NIH-11195489 · Data updated 2026-11-12
This program is working to help create and improve new treatments for heart, lung, blood, and sleep issues, making it easier for these promising therapies to reach patients like you who need them.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Research Triangle Institute NIH-funded |
| Lab location | 1 site (Research Triangle Park, United States) |
| Project start | September 30, 2022 |
| Project end | September 29, 2025 |
| Funding year | 2024 |
| Award (this year) | $783,720 |
| NIH project number | 92022A00592022F00001-P00002-0-1 |
| Project ID | NIH-11195489 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit from this research include individuals suffering from heart, lung, blood, or sleep disorders who are seeking new treatment options.
✕Less likely to help
Patients with conditions outside the scope of heart, lung, blood, and sleep disorders may not receive any benefit from this research.
What this research studies
This program provides essential services to support the preclinical development of innovative technologies aimed at preventing, diagnosing, and treating heart, lung, blood, and sleep disorders. It facilitates the transition from late-stage optimization of these technologies to regulatory approval, ensuring that promising treatments can move forward to clinical trials. Patients may benefit from advancements in therapies that address their specific conditions as the program aims to streamline the development process for new medical interventions.
Why it matters
Potential benefit: If successful, this research could lead to the development of groundbreaking treatments for various heart, lung, blood, and sleep disorders.
How similar studies have gone: Other research initiatives have successfully utilized similar preclinical development approaches to advance medical technologies, indicating a promising potential for this program.
Where this research is happening
-
Research Triangle Institute
Research Triangle Park, United States Active
Researchers
- Principal investigator: Severynse-Stevens, Diana — Research Triangle Institute
- Study coordinator: Severynse-Stevens, Diana
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.